Paul D. Rubin, Senior VP Clinical Development & CMO at XOMA Corp (XOMA), sold 1,788 shares at $3.60 ($6K) on 2015-05-28, disclosed to the SEC on 2015-06-01.
Open-market sale of $6k XOMA by Senior VP Clinical Development & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BIOA | SELL | 2026-02-03 | $139K | — | Filing → |
| BIOA | SELL | 2026-01-06 | $191K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |